Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Blay JY et al. - In advanced gastrointestinal stromal tumour, imatinib should be given until progression or intolerance and possibly after progression when patients have exhausted all other options. In the adjuvant setting, the optimal duration of imatinib treatment remains unknown.

Related Articles

Cutaneous metastasis from gastric glomus tumour
Clinical and Experimental Dermatology, 10/05/09    Relevance Score: 80%

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
The Lancet Oncology - Online First, 10/01/09    Relevance Score: 79%

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09    Relevance Score: 68%

Carney Triad in an Adult with Aggressive Behavior: The First Case in Korea
Yonsei Medical Journal, 10/30/09    Relevance Score: 66%

Collision tumor of the stomach: Gastric adenocarcinoma intermixed with gastrointestinal stromal tumor
Pathology International, 10/20/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address